Marcia Landa

Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease

Tazeen H. Jafar, Paul C. Stark, Christopher H. Schmid et al. · Kidney International · 2001 · 378 citations · Full text

Glomerulonephritis, Urology, Renal Disease +9

Progression Risk, Urinary Protein Excretion, and Treatment Effects of Angiotensin-Converting Enzyme Inhibitors in Nondiabetic Kidney Disease

David M. Kent, Tazeen H. Jafar, Rodney A. Hayward et al. · Journal of the American Society of Nephrology · 2007 · 162 citations

Hypertension, Urinary Protein Excretion, Creatinine Doubling +20

The value of breast lumpectomy margin assessment as a predictor of residual tumor burden in ductal carcinoma in situ of the breast

Andrew C. Neuschatz, Thomas A. DiPetrillo, Margaret M. Steinhoff et al. · Cancer · 2002 · 112 citations

Margin width as a determinant of local control with and without radiation therapy for ductal carcinoma in situ (DCIS) of the breast

Andrew C. Neuschatz, Thomas A. DiPetrillo, Homa Safaii et al. · International Journal of Cancer · 2001 · 36 citations · Full text

Margin Width, Local Control, Surgical Oncology +14

Constructing a database of individual clinical trials for longitudinal analysis

Christopher H. Schmid, Marcia Landa, Tazeen H. Jafar et al. · Controlled Clinical Trials · 2003 · 26 citations

Health Informatics, Clinical Trial Management, Clinical Database +14